SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nanalysis Settles $240,000 Note Interest With Shares; Interim CFO Steps Down

Nanalysis Scientific issued 2,000,000 common shares at a deemed price of $0.12 each to settle the first annual interest payment on its $2 million unsecured notes, subject to final TSX Venture Exchange approval. Interim CFO Philip Birkby stepped down effective October 31, 2026, and will remain as a consultant while the company searches for a permanent CFO.

NSCI

Related stories